A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT00429091 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
243
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Abbott